Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaAWBO:2HRA -0.31%40 Piotroski F-Score is 4 as of Jul. 25, 2026, which is 33% below its 10-year median of 6.00. GuruFocus rates WBO:2HRA with a GF Score™ of 40/100 and a GF Value™ of €4.25 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,561 Chemicals companies, H&R GmbH KGaA ranks worse than 65.53% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
H&R GmbH KGaA has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for H&R GmbH KGaA's Piotroski F-Score or its related term are showing as below:
WBO:2HRA'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 6 Max: 9
Current: 4
During the past 13 years, the highest Piotroski F-Score of H&R GmbH KGaA was 9. The lowest was 2. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
H&R GmbH KGaA Piotroski F-Score Related Terms
H&R GmbH KGaA Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:2HRA vs LIN, SHW, ECL: Piotroski F-Score Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA Piotroski F-Score vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
H&R GmbH KGaA's current Net Income (TTM) was -37.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
H&R GmbH KGaA's return on assets of this year was -0.03638828. H&R GmbH KGaA's return on assets of last year was 0.01112955.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
H&R GmbH KGaA's gearing of this year was 0.0180592. H&R GmbH KGaA's gearing of last year was 0.06008375.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
H&R GmbH KGaA's current ratio of this year was 1.30863801. H&R GmbH KGaA's current ratio of last year was 1.50607318.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
H&R GmbH KGaA's number of shares in issue this year was 38.95. H&R GmbH KGaA's number of shares in issue last year was 37.86.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
H&R GmbH KGaA's gross margin of this year was 0.2576346. H&R GmbH KGaA's gross margin of last year was 0.23824049.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
H&R GmbH KGaA's asset turnover of this year was 1.18301023. H&R GmbH KGaA's asset turnover of last year was 1.38707246.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
1
+
0
+
1
+
1
+
0
+
0
+
1
+
0
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
H&R GmbH KGaA has an F-score of 4 indicating the company's financial situation is typical for a stable company.
H&R GmbH KGaA (WBO:2HRA) has a Piotroski F-Score of 4 as of Jul. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on H&R GmbH KGaA and its competitors. This is 33% below median its historical median of 6.00. Over the past decade, H&R GmbH KGaA's Piotroski F-Score has ranged from 2.00 to 9.00. According to the industry distribution chart, H&R GmbH KGaA ranks #1023 out of 1561 companies in the Chemicals industry, placing it in the top 65.5%.
Is H&R GmbH KGaA's Piotroski F-Score too high?
H&R GmbH KGaA's current Piotroski F-Score of 4 is 33% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. The Chemicals industry median Piotroski F-Score is 5.00. H&R GmbH KGaA's value of 4 is 20% below this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #1023 out of 1561 companies in the Chemicals industry, which is below the industry midpoint. Overall, H&R GmbH KGaA has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Piotroski F-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #1023 out of 1561 companies for Piotroski F-Score. This places H&R GmbH KGaA in the lower half of its industry. The industry median Piotroski F-Score is 5.00. H&R GmbH KGaA's value of 4 is 20% below this benchmark. Historically, H&R GmbH KGaA's own Piotroski F-Score has ranged from 2.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, H&R GmbH KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Chemicals company?
The median Piotroski F-Score among Chemicals companies is 5.00, based on 1,561 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on H&R GmbH KGaA and its competitors. For the Chemicals industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current Piotroski F-Score is 4, which is 33% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (WBO:2HRA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.25, compared to a current price of €6.46 — trading 52% above its estimated fair value. The current Piotroski F-Score is 4, which is 33% below median its 10-year median of 6.00 and 20% below the Chemicals industry median of 5.00. H&R GmbH KGaA's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For H&R GmbH KGaA (WBO:2HRA), the current Piotroski F-Score is 4 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (WBO:2HRA) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.46 is trading 52% above its estimated GF Value™ of €4.25.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for WBO:2HRA:
Piotroski F-Score: 4 (33% below median its 10-year median of 6.00)
GF Value™: €4.25 vs. price of €6.46 (52% above fair value)
Industry Position: 20% below the Chemicals median (#1023 of 1561)
No single metric tells the full story. See the WBO:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
40GF Score
Get the complete analysis for WBO:2HRA
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:2HRA has been successfully added to your 
